Niamh-Maire McLennan

Niamh-Maire McLennan

Auto-generated profile, based on publicly available information

Niamh-Maire McLennan

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
NMNiamh‐Maire Mclennan
Niamh‐Maire Mclennan
RLRobert Lindsay
Robert Lindsay
Ponnusamy SaravananPonnusamy Saravanan
Ponnusamy Saravanan
NSNithya Sukumar
Nithya Sukumar
SWSara L White
Sara L White
TGthe Diabetes in Pregnancy Working Group
the Diabetes in Pregnancy Working Group
Objective: To determine the impact of implementing emergency care pathway(s) for screening, diagnosing and managing women with gestational diabetes (GDM) during COVID‐19.Design: Retrospective multicentre cohort.Setting: Nine National Health Service (NHS) Hospital Trusts/Health boards in England and Scotland.Population: 4915 women with GDM pre‐pandemic (1 April 2018 to 31 March 2020), and 3467 women with GDM during the pandemic (1 May 2020 to 31 March 2021).Methods: We examined clinical outcomes for women with GDM prior to and during the pandemic following changes in screening methods, diagnostic testing, glucose thresholds and introduction of virtual care for monitoring of antenatal glycaemia.Main Outcome Measures: Intervention at birth, perinatal mortality, large‐for‐gestational‐age infants and neonatal unit admission.Results: The new diagnostic criteria more often identified GDM women who were multiparous, had higher body mass index (BMI) and greater deprivation, and less frequently had previous GDM (all p < 0.05). During COVID, these women had no differences in the key outcome measures. Of the women, 3% were identified with pre‐existing diabetes at antenatal booking. Where OGTT continued during COVID, but virtual care was introduced, outcomes were also similar pre‐ and during the pandemic.Conclusions: Using HbA1c and fasting glucose identified a higher risk GDM population during the pandemic but this had minimal impact on pregnancy outcomes. The high prevalence of undiagnosed pre‐existing diabetes suggests that women with GDM risk factors should be offered HbA1c screening in early pregnancy.

17 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JBJamie L Benham
Jamie L Benham
Véronique GingrasVéronique Gingras
Véronique Gingras
NMNiamh-Maire McLennan
Niamh-Maire McLennan
JMJasper Most
Jasper Most
JYJennifer M Yamamoto
Jennifer M Yamamoto
APAda/Easd Pmdi
Ada/Easd Pmdi
We hypothesized that a precision medicine approach could be a tool for risk-stratification of women to streamline successful GDM management. With the relatively short timeframe available to treat GDM, commencing effective therapy earlier, with more rapid normalization of hyperglycaemia, could have benefits for both mother and fetus. We conducted two systematic reviews, to identify precision markers that may predict effective lifestyle and pharmacological interventions. There were a paucity of studies examining precision lifestyle-based interventions for GDM highlighting the pressing need for further research in this area. We found a number of precision markers identified from routine clinical measures that may enable earlier identification of those requiring escalation of pharmacological therapy. Whether there are other sensitive markers that could be identified using more complex individual-level data, such as ‘omics’, and if these can be implemented in clinical practice remains unknown. These will be important to consider in future studies.

3 August 2026 in BMJ Medicine
Verified
Journal Article
Open access
PDF file
CSCarlos Sánchez-Soriano
Carlos Sánchez-Soriano
NMNiamh-Maire McLennan
Niamh-Maire McLennan
SWSara L White
Sara L White
NSNithya Sukumar
Nithya Sukumar
Ponnusamy SaravananPonnusamy Saravanan
Ponnusamy Saravanan
RRRebecca Reynolds
Rebecca Reynolds
Objectives: To quantify the incidence of gestational diabetes mellitus in England, determine inequalities in diagnoses and pregnancy outcomes, and assess the indirect effects of the covid-19 pandemic. Design: Contemporary, cross sectional observational study. Setting: Primary and secondary care data from NHS England, based on the Hospital Episode Statistics Admitted Patient Care dataset, 1 January 2018 to 31 December 2022. Participants: 2 314 365 women, aged 16-50 years, who gave birth to 2 758 170 babies in 184 hospitals. Main outcome measures: Rates of gestational diabetes, infants born small for gestational age or large for gestational age, and emergency caesarean births, summarised yearly and monthly, based on socioeconomic deprivation and ethnic group. Results: Diagnoses of gestational diabetes increased from about 8% in 2018 to >12% in 2022. The increase was greatest for individuals from non-white ethnic groups (23% for Asian women) or those living in deprivation (14%). Mothers from these backgrounds were also at greater risk of adverse pregnancy outcomes, such as emergency caesarean birth (odds ratio for black mothers 1.36, 95% confidence interval 1.34 to 1.38), preterm birth (odds ratio for deprived mothers 1.29, 1.27 to 1.31), or having an infant small for gestational age (odds ratio for Asian mothers 2.42, 2.39 to 2.45). Also, a diagnosis of gestational diabetes for these women was associated with an increase in the odds of preterm birth. Changes to screening methodology for gestational diabetes during the covid-19 pandemic had no significant effect on the number of diagnoses. Conclusions: The study found that one in eight mothers in England had a diagnosis of gestational diabetes, and that profound health inequalities exist in their outcomes. Strategies are urgently needed to provide and improve care for this high risk group, given the implications of gestational diabetes on the short and long term health outcomes for mothers and babies.